HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Patientory harnessing blockchain to tackle population health
AI/ML

Patientory harnessing blockchain to tackle population health

4:33

Patientory's population health, data analytics and patient engagement app is built on a decentralized blockchain network, says CEO Chrissa McFarlane.

Read More
Read Less

AI/ML - Similar Videos View more in AI/ML

14:17

Consumer AI can't provide the trustworthy answers patients need

DeepLook Medical CEO Marissa Fayer cautions against using ChatGPT for medical advice and advocates for a balance between using digital technologies to empower patients and ensuring physicians remain trusted decision-makers.

Consumer AI can't provide the trustworthy answers patients need
DeepLook Medical CEO Marissa Fayer cautions against using ChatGPT for medical advice and advocates for a balance between using digital technologies to empower patients and ensuring physicians remain trusted decision-makers.
14:17
7:52

AI is driving down clinical denial rates

Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.

AI is driving down clinical denial rates
Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.
7:52
6:41

The need to move AI regulation faster

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The need to move AI regulation faster
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
6:41